173 related articles for article (PubMed ID: 20119883)
1. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.
Catena C; Colussi G; Di Fabio A; Valeri M; Marzano L; Uzzau A; Sechi LA
Horm Metab Res; 2010 Jun; 42(6):440-5. PubMed ID: 20119883
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.
Sechi LA; Colussi G; Di Fabio A; Catena C
Am J Hypertens; 2010 Dec; 23(12):1253-60. PubMed ID: 20706195
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
4. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of primary aldosteronism.
Boscaro M; Ronconi V; Turchi F; Giacchetti G
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):332-8. PubMed ID: 18594273
[TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone and cardiovascular disease.
Gaddam KK; Pimenta E; Husain S; Calhoun DA
Curr Probl Cardiol; 2009 Feb; 34(2):51-84. PubMed ID: 19135616
[TBL] [Abstract][Full Text] [Related]
9. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
10. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F
Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities in primary aldosteronism.
Quinkler M; Born-Frontsberg E; Fourkiotis VG
Horm Metab Res; 2010 Jun; 42(6):429-34. PubMed ID: 20049673
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of primary aldosteronism.
Mulatero P; Monticone S; Bertello C; Tizzani D; Iannaccone A; Crudo V; Veglio F
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):188-93. PubMed ID: 20389241
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of surgical and conservative treatment of patients with primary aldosteronism.
Horký K; Widimský J; Hradec E; Gregorová I; Hradec M
Exp Clin Endocrinol; 1987 Dec; 90(3):337-46. PubMed ID: 3450533
[TBL] [Abstract][Full Text] [Related]
14. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
Marzano L; Colussi G; Sechi LA; Catena C
Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
[TBL] [Abstract][Full Text] [Related]
15. Relative glomerular hyperfiltration in primary aldosteronism.
Ribstein J; Du Cailar G; Fesler P; Mimran A
J Am Soc Nephrol; 2005 May; 16(5):1320-5. PubMed ID: 15800124
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
Sechi LA; Colussi GL; Novello M; Uzzau A; Catena C
Horm Metab Res; 2015 Dec; 47(13):1000-6. PubMed ID: 26667803
[TBL] [Abstract][Full Text] [Related]
17. [Aldosterone].
Tanabe A; Tsuiki M; Watanabe D; Takagi S; Takano K; Naruse M
Rinsho Byori; 2004 Aug; 52(8):704-10. PubMed ID: 15478626
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
Milliez P; Girerd X; Plouin PF; Blacher J; Safar ME; Mourad JJ
J Am Coll Cardiol; 2005 Apr; 45(8):1243-8. PubMed ID: 15837256
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
[TBL] [Abstract][Full Text] [Related]
20. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
